Astrocyte Pharmaceuticals
Dr. Lechleiter is the Co-Founder and Advisor of Astrocyte Pharmaceuticals, and he is currently a Professor of Cellular and Structural Biology at the University of Texas Health Science Center at San Antonio. His research investigates the molecular and cellular mechanisms of protection during ischemic stress, acute brain injury, and aging. His major focus has been to understand the role of astrocyte mitochondrial ATP production in these processes. He has extensive experience with imaging technology, its application towards current problems in cell biology and he is the director of the institution’s Optical Imaging facility. Academically, he is a member of the executive committee of the Center for Biomedical Neuroscience.
Dr. Lechleiter is a member of the Biophysical Society, the Society for Neuroscience and he was an associate member of the editorial review board of the Journal of Biological Chemistry. Scientifically, he is widely recognized for his seminal work in the field of Ca2+ signaling where he made the initial discovery of intracellular spiral Ca2+ waves.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Astrocyte Pharmaceuticals
Astrocyte Pharmaceuticals is pursuing an innovative neuroprotective strategy to protect and repair neurons that are damaged by selectively stimulating astrocytes. The company is investigating and advancing small molecule pharmaceutical medicines that will provide neuroprotection to a range of brain injury patients.